Chediak-Higashi Syndrome Terminated Phase 2 / 3 Trials for Cyclophosphamide (DB00531)

Also known as: Begnez Cesar disease / Alder (granulation) (granulocyte) anomaly

IndicationStatusPhase
DBCOND0029163 (Chediak-Higashi Syndrome)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic DisordersTreatment